Selected countries include a "substantially comparable" capture-all clause within their drug legislation, for instance New Zealand and Australia. This involves six-APB as it is analogous in chemical construction to The category A drug MDA, this means 6-APB could possibly be viewed to be a managed substance analogue in these jurisdictions.[19]When u